These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7676489)

  • 21. Leflunomide therapy following penetrating keratoplasty in the rat.
    Coupland SE; Klebe S; Karow AC; Krause L; Kruse H; Bartlett RR; Hoffmann F
    Graefes Arch Clin Exp Ophthalmol; 1994 Oct; 232(10):622-7. PubMed ID: 8001831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. As2 O3 combined with leflunomide prolongs heart xenograft survival via suppressing the response of Th1, Th2, and B cells in a rat model.
    Jiao ZX; Leng Y; Xia JJ; Wu HQ; Jin N; Fu JZ; Cheng LN; Wang JH; Ni SB; Qi ZQ
    Xenotransplantation; 2016 May; 23(3):237-48. PubMed ID: 27188662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat.
    Bilolo KK; Ouyang J; Wang X; Zhu S; Jiang W; Qi S; Xu D; Hebert MJ; Bekersky I; Fitzsimmons WE; Chen H
    Transplantation; 2003 Jun; 75(11):1881-7. PubMed ID: 12811249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
    Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
    Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malononitrilamides 715 and 279 prevent accelerated cardiac allograft rejection synergistically with cyclosporin A in presensitized rats.
    Qi Z; Simanaitis M; Ekberg H
    Transpl Immunol; 1998 Jun; 6(2):94-100. PubMed ID: 9777697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent antiviral and immunosuppressive activities of leflunomide in vivo.
    Chong AS; Zeng H; Knight DA; Shen J; Meister GT; Williams JW; Waldman WJ
    Am J Transplant; 2006 Jan; 6(1):69-75. PubMed ID: 16433758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A short-term combination therapy with cyclosporine and rapamycin or leflunomide induces long-term heart allograft survival in a strongly immunogenic strain combination in rats.
    Lin Y; Vandeputte M; Waer M
    Transpl Int; 1996; 9 Suppl 1():S328-30. PubMed ID: 8959857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malononitrilamides 715 and 279 prolong rat cardiac allograft survival, reverse ongoing rejection, inhibit allospecific antibody production and interact positively with cyclosporin.
    Qi Z; Ekberg H
    Scand J Immunol; 1998 Oct; 48(4):379-88. PubMed ID: 9790308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine.
    Wang J; Xu R; Jin R; Chen Z; Fidler JM
    Transplantation; 2000 Aug; 70(3):447-55. PubMed ID: 10949186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immunopharmacology of immunosuppression by 15-deoxyspergualin.
    Yuh DD; Morris RE
    Transplantation; 1993 Mar; 55(3):578-91. PubMed ID: 7681226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The synergism of brequinar sodium and cyclosporine used in combination to prevent cardiac allograft rejection in the rat.
    Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L
    Transplantation; 1993 Sep; 56(3):667-72. PubMed ID: 8212165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts.
    Pan F; Ebbs A; Wynn C; Erickson L; Jang MS; Crews G; Fisniku O; Kobayashi M; Paul LC; Benediktsson H; Jiang AH
    Transplantation; 2003 Apr; 75(8):1110-4. PubMed ID: 12717186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FK778 and FK506 combination therapy to control acute rejection after rat liver allotransplantation.
    Yamamoto S; Okuda T; Yamasaki K; Tanaka H; Kubo S; Takemura S; Ikeda K; Minamiyama Y; Hirohashi K; Suehiro S
    Transplantation; 2004 Dec; 78(11):1618-25. PubMed ID: 15591950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanistic study of malononitrileamide FK778 in cardiac transplantation and CMV infection in rats.
    Zeng H; Waldman WJ; Yin DP; Knight DA; Shen J; Ma L; Meister GT; Chong AS; Williams JW
    Transplantation; 2005 Jan; 79(1):17-22. PubMed ID: 15714164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination treatment effectively intercepts advanced acute cardiac rejection.
    Antoniou EA; Xu M; Howie A; Chondros K; McMaster P; D'Silva M
    Transplant Proc; 1997 Nov; 29(7):2888-91. PubMed ID: 9365604
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats.
    Ochiai T; Nakajima K; Nagata M; Hori S; Asano T; Isono K
    Transplantation; 1987 Dec; 44(6):734-8. PubMed ID: 2447689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flow-cytometric analysis of peripheral lymphocytes in the rat following penetrating keratoplasty and immunosuppressive treatment.
    Klebe S; Coupland SE; Krause L; Hoffmann F
    Ger J Ophthalmol; 1996 May; 5(3):137-45. PubMed ID: 8803575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of leflunomide in combination with current immunosuppressive agents in rat cardiac allotransplantation.
    Candinas D; Achilleos O; Lee SJ; Dalgic A; Mayer AD; Buckels JA; McMaster P; D'Silva M
    Transplant Proc; 1994 Dec; 26(6):3251-2. PubMed ID: 7527959
    [No Abstract]   [Full Text] [Related]  

  • 39. Cyclosporin A for immunosuppression: observations in rat heart, pancreas, and islet allograft models and in human renal and pancreas transplantation.
    Rynasiewicz JJ; Sutherland DE; Ferguson RM; Squifflet JP; Morrow CE; Goetz FC; Najarian JS
    Diabetes; 1982 Aug; 31 Suppl 4():92-108. PubMed ID: 6819969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat.
    Vu MD; Qi S; Xu D; Wu J; Fitzsimmons WE; Sehgal SN; Dumont L; Busque S; Daloze P; Chen H
    Transplantation; 1997 Dec; 64(12):1853-6. PubMed ID: 9422432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.